Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Operations (Unaudited)

v3.21.2
Condensed Consolidated Statements of Operations (Unaudited) - USD ($)
$ in Thousands
 3 Months Ended 6 Months Ended
Jun. 30, 2021
Jun. 30, 2020
Jun. 30, 2021
Jun. 30, 2020
Income Statement [Abstract]        
Product revenue $ 101 $ 204 $ 202 $ 411
Costs of revenue 73 163 134 329
Gross profit 28 41 68 82
Operating expenses:        
Research and development 1,204 1,068 2,799 2,061
General and administrative 858 826 1,858 1,591
Sales and marketing 329 131 615 268
Total operating expenses 2,391 2,025 5,272 3,920
Loss from operations (2,363) (1,984) (5,204) (3,838)
Other income (expenses):        
Interest expense (1) (1) (1) (1)
Interest income 49 85 96 189
Change in fair value of derivative liabilities (14) (2,128) (256) 2,037
Offering costs (1,246)
Forgiveness of PPP loan 391
Other income, net 130 142
Total other income (expense), net 164 (2,044) 372 979
Net loss before income taxes (2,199) (4,028) (4,832) (2,859)
Provision for income taxes
Net loss (2,199) (4,028) (4,832) (2,859)
Deemed dividend related to the beneficial conversion feature and accretion of a discount on series B preferred stock (207) (9,491)
Net loss attributable to common stockholders $ (2,199) $ (4,235) $ (4,832) $ (12,350)
Net loss per share – basic and diluted        
Basic – net loss $ (0.09) $ (0.33) $ (0.20) $ (0.32)
Basic - deemed dividend and accretion of a discount on conversion of preferred stock (0.02) (1.05)
Basic – attributable to common stockholders (0.09) (0.35) (0.20) (1.37)
Diluted –net loss (0.09) (0.33) (0.20) (0.45)
Diluted - deemed dividend and accretion of a discount on conversion of preferred stock (0.02) (0.84)
Diluted – attributable to common stockholders $ (0.09) $ (0.35) $ (0.20) $ (1.29)
Weighted average common shares outstanding:        
Basic 24,687,916 12,120,420 24,678,084 9,070,655
Diluted 24,687,916 12,120,420 24,678,084 11,314,252